# LEXISCAN
> **NDA022161** · New Drug Application · Sponsor: ASTELLAS · Approved 2008-04-10
## Drug
- **FDA Application Number:** NDA022161
- **Application type:** New Drug Application
- **Brand name:** LEXISCAN
- **Generic name:** REGADENOSON
- **Active ingredients:** REGADENOSON
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ASTELLAS
- **Manufacturer:** Astellas Pharma US, Inc.
- **First approval:** 2008-04-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022161)
---
*AI Analytics · CC0 1.0*